Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase π

Archives of Dermatology

Volumn 145, Issue 1, 2009, Pages 55-62

  Orlandi, Augusto ^a   Costantini, Sara ^a   Campione, Elena ^a   Ferlosio, Amedeo ^a   Amantea, Ada ^b   Bianchi, Luca ^a   Chimenti, Sergio ^a   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; MELAN A; PROTEIN S 100; VIMENTIN;

ADULT; AGED; ANIMAL TYPE MELANOMA; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; DISEASE COURSE; FEMALE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTROSPECTION; MALE; MELANOCYTE; MELANOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN PIGMENTATION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL NUCLEUS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; S100 PROTEINS; SKIN NEOPLASMS; VIMENTIN; YOUNG ADULT;

EID: 58849149826     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.145.1.55     Document Type: Article

References (35)

1. Kazakov DV, Rütten A, Kempf W, et al. Melanoma with prominent pigment synthesis (animal-type melanoma): a case report with ultrastructural studies. Am J Dermatopathol. 2004;26(4):290-297.
2. Crowson AN, Magro CM, Mihm MC, et al. Malignant melanoma with prominent pigment synthesis: "animal-type" melanoma: a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol. 1999;30(5):543-550.
3. Requena L, De la Cruz A, Moreno C, et al. Animal type melanoma: a report of a case with balloon-cell change and sentinel lymph node metastasis. Am J Dermatopathol. 2001;23(4):341-346.
4. Antony FC, Sanclemente G, Shaikh H. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology. 2006;48(6):754-762.
5. Dick W. Melanosis in men and horses [letter]. Lancet. 1832:192:8.
6. Levene A. Disseminated dermal melanocytosis terminating in melanoma: a human condition resembling equine melanotic disease. Br J Dermatol. 1979;101(2):197-205.
7. Tuthill RJ, Clark WH, Levene A. Pilar neurocristic hamartoma: its relationship to blue nevus and equine melanotic disease. Arch Dermatol. 1982;118(8):592-596.
8. Darier J. Le melanome malin mesenchymateaux ou melanosarcome. Bull Assoc Fr Cancer. 1925;14:221-249.
9. Pathy AL, Helm TN, Elston D, et al. Malignant melanoma arising in a blue nevus with features of pilar neurocristic hamartoma. J Cutan Pathol. 1993;20(5):459-464.
10. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648.
11. Townsend DM, Tew KD. The role of glutathione-S-tranferase in anticancer drug resistance. Oncogene. 2003;22(47):7369-7375.
12. Ketterer B, Meyer DJ. Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat Res. 1989;214(1):33-40.
13. Campbell JAH, Corrigal AV, Guy A, et al. Immunohistologic localization of alpha, mu and pi class glutathione S-transferases in human tissues. Cancer. 1991;67(6):1608-1613.
14. Moral A, Palou J, Lafluente A, et al. Immunohistochemical study of alpha, mu and pi class glutathione S transferase expression in malignant melanoma. Br J Dermatol. 1997;136(3):345-350.
15. Schadendorf D, Jurgovsky K, Kohlmus CM, et al. Glutathione and related enzymes in tumour progression and metastases of human melanoma. J Invest Dermatol. 1995;105(1):109-112.
16. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004;28(1):31-40.
17. Carney JA, Ferreiro JA. The epithelioid blue nevus: a multicentric familiar tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996;20(3):259-272.
18. Orchard GE, Calonje E. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms. Am J Dermatopathol. 1998;20(4):357-361.
19. Milette F, Ackerman AB. "Animal-Type Melanoma" and "Entities" Related to It: Exegesis of a Subject Until Now Incomprehensible. New York, NY: Ardor Scribendi; 2006.
20. Rodriguez HA, Ackerman LV. Cellular blue nevus: clinicopathologic study of forty-five cases. Cancer. 1968;21(3):393-405.
21. Aloi F, Pich A, Pippione M. Malignant cellular blue nevus: a clinicopathologic study of 6 cases. Dermatology. 1996;192(1):36-40.
22. Reed RJ, Ichinose H, Clark WH Jr, et al. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol. 1975;2(2):119-147.
23. Ackerman AB, Guo Y, Vitale P. Clues to Diagnosis in Dermatopathology II. Chicago, IL: ASCP Press; 1992:273-276.
24. White S, Chen S. What is "pigmented epithelioid melanocytoma"? [letter]. Am J Surg Pathol. 2005;29(8):1118.
25. Eimoto H, Tsutsumi M, Nakajima A, et al. Expression of the glutathione S-transferase placental form in human lung carcinomas. Carcinogenesis. 1988;9(12):2325-2327.
26. Brabender J, Reginald V, Kumari W, et al. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma. J Gastrointest Surg. 2002;6(3):359-367.
27. Rappa G, Lorico A, Flavell RA, et al. Evidence that the multidrug resistance protein 1 (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 1997;57(23):5232-5237.
28. Depeille P, Cuq P, Mary S, et al. Glutathione S-transferase M1 and multidrugs resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol Pharmacol. 2004;65(4):897-905.
29. Goto S, Yoshida K, Morikawa T, et al. Augmentation of transport for cisplatin-glutathione adduct in cisplatin resistant cancer cells. Cancer Res. 1995;55(19):4297-4301.
30. Zaman GJ, Flens MJ, van Leusden MR, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1995;92(17):7690-7696.
31. Goto S, Ihara Y, Urata Y, et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-tranferase pi. FASEB J. 2001;15(14):2702-2714.
32. Zembowicz A, Knoepp SM, Bei T, et al. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol. 2007;31(11):1764-1775.
33. Soh Y, Goto S, Kitajima M, et al. Nuclear localization of glutathione S-tranferase pi is an evaluation factor for drug resistance in gynaecological cancer. Clin Oncol (R Coll Radiol). 2005;17(4):264-270.
34. Gate L, Majumdar RS, Lunk A, et al. Influence of glutathione S-tranferase pi and p53 expression on tumour frequency and spectrum in mice. Int J Cancer. 2005;113(1):29-35.
35. Keller G, Lacaud G, Robertson S. Development of the hematopoietic system in the mouse. Exp Hematol. 1999;27(5):777-787.